Company Overview and News


Add GMED
to your dashboard

Headline News

Globus Medical (GMED) Looks Good: Stock Adds 7.5% in Session

2017-11-10 zacks
Globus Medical, Inc. (GMED - Free Report) was a big mover last session, as the company saw its shares rise nearly 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $28.86–$31.87 in the past one-month time frame, witnessed a sharp increase yesterday. (2-0)

Globus Medical (GMED) Q3 2017 Results - Earnings Call Transcript

2017-11-09 seekingalpha
Welcome to Globus Medical's Third Quarter 2017 Earnings Call. At this time, all lines will be on mute and a Q&A session will be held after the prepared remarks. (52-0)

Brief Study of Paradigm Select Fund (PFSLX)

2017-10-24 zacks
Paradigm Select Fund (PFSLX - Free Report) seeks appreciation of capital for the long run. PFSLX invests mainly in common stocks of those companies, whose market-cap falls within the range of $500 million and $10 billion. PFSLX focuses on those companies which are expected to have strong capital growth potential. (1-0)

Globus Medical Announces First Spine Surgeries Using ExcelsiusGPS

2017-10-11 devicespace
AUDUBON, Pa., Oct. 10, 2017 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced the first spine surgeries using ExcelsiusGPS™, a revolutionary robotic guidance and navigation system. Surgeries using ExcelsiusGPS™ were performed last week at The Johns Hopkins Hospital in Baltimore, Maryland and St. Mark’s Hospital in Salt Lake City, Utah.

Europe Orthobiologics Market by Product, by End-User, by Geography - Analysis & Forecast to 2019

2017-10-04 prnewswire
LONDON, Oct. 4, 2017 /PRNewswire/ -- The European orthobiologics market is estimated to grow at a CAGR of 6.3% from 2014 to 2019. It is the second-largest market in the global orthobiologics market, followed by North America. Download the full report: https://www.reportbuyer.com/product/4167856 Increasing cases of road accidents, as well as rising prevalence of osteoarthritis are propelling the growth of orthobiologics market in this region. (6-0)

Orthobiologics Market by Product, by End-User - Global Forecast to 2019

2017-10-04 prnewswire
LONDON, Oct. 4, 2017 /PRNewswire/ -- The global orthobiologics market is estimated to grow at a CAGR of 6.7% from 2014 to 2019. The end-user segment of this market is classified into hospitals, orthopedic clinics, and other end-users. Rise in cases of road accidents, as well as increasing awareness among patients with regards to the benefits associated with orthobiologics products are propelling the growth of orthobiologics market. (6-0)

Orthobiologics Market by Product, Application, End User - Global Forecast to 2022

2017-10-04 prnewswire
NEW YORK, Oct. 3, 2017 /PRNewswire/ -- The global orthobiologics market is projected to reach USD 6.06 billion by 2022 from USD 4.66 billion in 2017, at a CAGR of 5.4%. Factors such as rising burden of orthopedic injuries; increasing incidence of sports injuries and road accidents; increasing incidence of spinal fusion surgeries; risk factors associated with increasing aging population, obesity rate, & high incidence of musculoskeletal disorders; and growing patient preference for minimally invasive procedures are driving the orthobiologics market. (0-1)

The Top 200 Manufacturers of Orthopedic & Dental Implants Worldwide

2017-10-04 prnewswire
NEW YORK, Oct. 3, 2017 /PRNewswire/ -- Did you know?- Globus Medical's single-minded focus on advancing spinal surgery has made it the fastest growing company in the history of orthopedics. (15-1)

Zimmer Biomet: A Leading Medtech Player Facing Short-Term Issues

2017-09-29 seekingalpha
Zimmer (ZBH) is a US medical devices company focusing on orthopedic implants. Before delving into the company specificities, we are going to have a look to the orthopedic market. (18-0)

Orthopedic Biomaterials Market 13.19% CAGR by 2021 Biodegradable and Biocompatible Product Demand Rising

2017-09-29 prnewswire
Global Orthopaedic Biomaterial Market driven by rising clinical education among the patients, increasing medical applications of biomaterial by orthopaedicians, rising demand from the aged population, and technological innovation has further led to growing focus towards healthcare, hence, building the need for joint replacement surgeries using orthopaedic biomaterial, specifically among the adult population according to ReportsnReports. (37-2)

Orthobiologics Market Worth 6.06 Billion USD by 2022

2017-09-27 prnewswire
According to a new market research report "Orthobiologics Market by Product (Viscosupplementation, Synthetic Orthobiologics, DBM, BMP, PRP, BMAC, Allograft), Application (Fracture Recovery, Osteoarthritis, Spinal Fusion, Soft Tissue), End User (Hospitals, ASCs, Academia) - Global Forecast to 2022", published by MarketsandMarkets™, the market is projected to reach USD 6.06 Billion by 2022 from USD 4. (6-0)

Globus Medical Announces First Case In Orthopedic Trauma

2017-09-15 devicespace
AUDUBON, Pa., Sept. 14, 2017 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced it completed its first orthopedic trauma surgical case. Globus Medical’s new ANTHEM™ Distal Radius Fracture System was used by Dr. Asif Ilyas, Hand Surgeon and Trauma Surgeon with The Rothman Institute at Thomas Jefferson University in Philadelphia PA, to successfully treat a distal radius fracture. (1-0)

Soft Tissue Allografts Market, Tendon Allografts, Meniscus Allografts, Dental Allografts, Collagen Allografts, and Amniotic Allografts - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025

2017-09-13 prnewswire
NEW YORK, Sept. 13, 2017 /PRNewswire/ -- This report on the soft tissue allografts market analyzes the current and future scenario of the global market. Large number of ACL injury patient and diabetes sufferers is increasing the usage of soft tissue allografts. Increasing prevalence of degenerative joint diseases and high definition designed technology are the major drivers of the global soft tissue allografts market.

Globus Medical's Robotic Guidance System Gets FDA Approval

2017-08-18 zacks
Based in Audubon, PA, leading musculoskeletal implant company Globus Medical, Inc. (GMED - Free Report) announced the receipt of 510k approval for its Excelsius GPS robotic guidance and navigation system from the FDA.

CUSIP: 379577208